Rye-based evening meals favorably affected glucose regulation and appetite variables at the following breakfast; a randomized controlled study in healthy subjects

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Sandberg, Jonna C ^a   Björck, Inger M E ^a   Nilsson, Anne C ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; GLUCOSE; HYDROGEN; INSULIN; SHORT CHAIN FATTY ACID; CALCIUM BINDING PROTEIN; DNA BINDING PROTEIN; GASTROINTESTINAL HORMONE; GLUCOSE BLOOD LEVEL; LIPID; NERVE PROTEIN; NUCLEOBINDIN;

ADULT; ARTICLE; CARDIOMETABOLIC RISK; CONTROLLED STUDY; EVENING MEAL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; MEAL; NORMAL HUMAN; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RYE; SATIETY; WHOLE GRAIN; BLOOD; BODY MASS; DIET THERAPY; FOOD INTAKE; HUNGER; INSULIN RESISTANCE; OBESITY; SECALE;

ADULT; APPETITE REGULATION; BLOOD GLUCOSE; BODY MASS INDEX; BREAKFAST; CALCIUM-BINDING PROTEINS; DIET THERAPY; DNA-BINDING PROTEINS; FEMALE; GASTROINTESTINAL HORMONES; HUMANS; HUNGER; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MEALS; NERVE TISSUE PROTEINS; OBESITY; SECALE;

EID: 84962423938     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151985     Document Type: Article

References (56)

1. Global status report on noncommunicable diseases 2014 Geneva: World Health Organization 2015. vailable: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854-eng.pdf?ua=1.
2. Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater Whole-Grain Intake Is Associated with Lower Risk of Type 2 Diabetes, Cardiovascular Disease, and Weight Gain. J Nutr. 2012; 142:1304-13. doi: 10.3945/jn.111.155325 PMID: 22649266
3. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med. 2007; 4:e261. MID: 17760498
4. Williams PG, Grafenauer SJ, O'Shea JE. Cereal grains, legumes, and weight management: a comprehensive review of the scientific evidence. Nutr Rev. 2008; 66:171-82. doi: 10.1111/j.1753-4887.2008. 0022.x PMID: 18366531
5. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006; 40:235-43. PMID: 16633129
6. Johansson EV, Nilsson AC, Ostman EM, Bjorck IM. Effects of indigestible carbohydrates in barley on glucose metabolism, appetite and voluntary food intake over 16 h in healthy adults. Nutr J. 2013; 12:46. oi: 10.1186/1475-2891-12-46 PMID: 23577719
7. Nilsson A, Granfeldt Y, Ostman E, Preston T, Bjorck I. Effects of GI and content of indigestible carbohydrates of cereal-based evening meals on glucose tolerance at a subsequent standardised breakfast. Eur J Clin Nutr. 2006; 60:1092-9. PMID: 16523203
8. Nilsson AC, Ostman EM, Holst JJ, Bjorck IM. Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr. 2008; 138:732-9. PMID: 18356328
9. Nilsson AC, Ostman EM, Knudsen KE, Holst JJ, Bjorck IM. A cereal-based evening meal rich in indigestible carbohydrates increases plasma butyrate the next morning. J Nutr. 2010; 140:1932-6. doi: 10. 3945/jn.110.123604 PMID: 20810606
10. Isaksson H, Fredriksson H, Andersson R, Olsson J, Aman P. Effect of rye bread breakfasts on subjective hunger and satiety: a randomized controlled trial. Nutr J. 2009; 8:39. doi: 10.1186/1475-2891-8-39 MID: 19709412
11. Isaksson H, Tillander I, Andersson R, Olsson J, Fredriksson H, Webb DL, et al. Whole grain rye breakfast-sustained satiety during three weeks of regular consumption. Physiol Behav. 2012; 105:877-84. MID: 22061429
12. Rosen LA, Silva LO, Andersson UK, Holm C, Ostman EM, Bjorck IM. Endosperm and whole grain rye breads are characterized by low post-prandial insulin response and a beneficial blood glucose profile. Nutr J. 2009; 8:42. doi: 10.1186/1475-2891-8-42 PMID: 19781071
13. Rosen LA, Ostman EM, Bjorck IM. Postprandial glycemia, insulinemia, and satiety responses in healthy subjects after whole grain rye bread made from different rye varieties. 2. J Agric Food Chem. 2011; 59:12149-54. doi: 10.1021/jf2019837 PMID: 21981244
14. Rosen LA, Ostman EM, Bjorck IM. Effects of cereal breakfasts on postprandial glucose, appetite regulation and voluntary energy intake at a subsequent standardized lunch; focusing on rye products. Nutr J. 2011; 10:7. doi: 10.1186/1475-2891-10-7 PMID: 21247415
15. Nilsson AC, Ostman EM, Granfeldt Y, Bjorck IM. Effect of cereal test breakfasts differing in glycemic index and content of indigestible carbohydrates on daylong glucose tolerance in healthy subjects. Am J Clin Nutr. 2008; 87:645-54. PMID: 18326603
16. Ibrugger S, Vigsnaes LK, Blennow A, Skuflic D, Raben A, Lauritzen L, et al. Second meal effect on appetite and fermentation of wholegrain rye foods. Appetite. 2014; 80:248-56. doi: 10.1016/j.appet. 2014.05.026 PMID: 24874564
17. Frolich W, Aman P, Tetens I. Whole grain foods and health-a Scandinavian perspective. Food Nutr Res. 2013; 57.
18. Nilsson AC, Johansson-Boll EV, Bjorck IM. Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: a randomised cross-over study in healthy middle-aged subjects. Br J Nutr. 2015:1-9.
19. Priebe MG, Wang H, Weening D, Schepers M, Preston T, Vonk RJ. Factors related to colonic fermentation of nondigestible carbohydrates of a previous evening meal increase tissue glucose uptake and moderate glucose-associated inflammation. Am J Clin Nutr. 2010; 91:90-7. doi: 10.3945/ajcn.2009. 8521 PMID: 19889821
20. Björck IME, Siljeström MA. In-vivo and in-vitro digestibility of starch in autoclaved pea and potato products. J Sci Food Agric. 1992; 58:541-53.
21. Akerberg AK, Liljeberg HG, Granfeldt YE, Drews AW, Bj-orck IM. An in vitro method, based on chewing, to predict resistant starch content in foods allows parallel determination of potentially available starch and dietary fiber. J Nutr. 1998; 128:651-60. PMID: 9482777
22. Asp NG, Johansson CG, Hallmer H, Siljestrom M. Rapid enzymatic assay of insoluble and soluble dietary fiber. J Agric Food Chem. 1983; 31:476-82. PMID: 6309935
23. Brighenti F. Summary of the conclusion of the working group on Profibre interlaboratory study on determination of short chain fatty acids in blood. In: Gullion F, Amadò R, Amaral-Collaco MT, Andersson H, Asp NG, Knudsen KEB, et al., editors. Functional properties of non-digestible carbohydrates. Brussels, Belgium: European Comission, DG XII, Science, Research and Development; 1998. p. 150-3.
24. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22:1462-70. PMID: 10480510
25. Isaksson H, Rakha A, Andersson R, Fredriksson H, Olsson J, Aman P. Rye kernel breakfast increases satiety in the afternoon-an effect of food structure. Nutr J. 2011; 10:31. doi: 10.1186/1475-2891-10-31 MID: 21481225
26. Isaksson H, Sundberg B, Aman P, Fredriksson H, Olsson J. Whole grain rye porridge breakfast improves satiety compared to refined wheat bread breakfast. Food Nutr Res. 2008; 52.
27. Andersson AAM, Dimberg L, Åman P, Landberg R. Recent findings on certain bioactive components in whole grain wheat and rye. J Cereal Sci. 2014; 59:294-311.
28. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 2005; 54:1640-8. PMID: 15919784
29. Wolever TM, Spadafora P, Eshuis H. Interaction between colonic acetate and propionate in humans. Am J Clin Nutr. 1991; 53:681-7. PMID: 2000822
30. Wolever TM, Brighenti F, Royall D, Jenkins AL, Jenkins DJ. Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol. 1989; 84:1027-33. PMID: 2773895
31. Tasyurek HM, Altunbas HA, Balci MK, Sanlioglu S. Incretins: their physiology and application in the treatment of diabetes mellitus. Diabetes Metab Res Rev. 2014; 30:354-71. doi: 10.1002/dmrr.2501 MID: 24989141
32. Lee YS, Jun HS. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells. Metabolism. 2014; 63:9-19. doi: 10.1016/j.metabol.2013.09.010 PMID: 24140094
33. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med. 1992; 326:1316-22. MID: 1348845
34. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002; 359:824-30. PMID: 11897280
35. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998; 101:515-20. PMID: 9449682
36. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM, et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab. 2001; 86:4382-9. PMID: 11549680
37. Gutzwiller J-P, Göke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut. 1999; 44:81-6. PMID: 9862830
38. Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A, et al. Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients. Diabetes. 2008; 57:1340-8. PMID: 18162504
39. Færch K, Torekov SS, Vistisen D, Johansen NB, Witte DR, Jonsson A, et al. Glucagon-Like Peptide-1 (GLP-1) Response to Oral Glucose is Reduced in Pre-diabetes, Screen-detected Type 2 Diabetes and Obesity, and Influenced by Sex: The ADDITION-PRO Study. Diabetes. 2015.
40. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002; 418:650-4. PMID: 12167864
41. Guo Y, Ma L, Enriori PJ, Koska J, Franks PW, Brookshire T, et al. Physiological Evidence for the Involvement of Peptide YY in the Regulation of Energy Homeostasis in Humans. Obesity (Silver Spring). 2006; 14:1562-70.
42. Roux CWl, Batterham RL, Aylwin SJB, Patterson M, Borg CM, Wynne KJ, et al. Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety. Endocrinology. 2006; 147:3-8. PMID: 16166213
43. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, et al. Inhibition of Food Intake in Obese Subjects by Peptide YY3-36. New England Journal of Medicine. 2003; 349:941-8. PMID: 12954742
44. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001; 86:5992. PMID: 11739476
45. Oh IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006; 443:709-12. PMID: 17036007
46. Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept. 2010; 159:72-7. doi: 10.1016/j.regpep.2009.11.003 PMID: 19896982
47. Tsuchiya T, Shimizu H, Yamada M, Osaki A, Oh-I S, Ariyama Y, et al. Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf). 2010; 73:484-90.
48. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009; 58:1091-103. doi: 10.1136/gut.2008.165886 PMID: 19240062
49. Hansen HB, Moller B, Andersen SB, Jorgensen JR, Hansen A. Grain characteristics, chemical composition, and functional properties of rye (Secale cereale L.) as influenced by genotype and harvest year. J Agric Food Chem. 2004; 52:2282-91. PMID: 15080634
50. Nielsen TS, Laerke HN, Theil PK, Sorensen JF, Saarinen M, Forssten S, et al. Diets high in resistant starch and arabinoxylan modulate digestion processes and SCFA pool size in the large intestine and faecal microbial composition in pigs. Br J Nutr. 2014; 112:1837-49. doi: 10.1017/S000711451400302X PMID: 25327182
51. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012; 61:364-71. doi: 10.2337/db11-1019 PMID: 22190648
52. Tarini J, Wolever TM. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab. 2010; 35:9-16. oi: 10.1139/H09-119 PMID: 20130660
53. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009; 90:1236-43. doi: 10.3945/ajcn. 2009.28095 PMID: 19776140
54. Kaji I, Karaki S, Kuwahara A. Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release. Digestion. 2014; 89:31-6. doi: 10.1159/000356211 PMID: 24458110
55. Karaki S, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, Suzuki Y, et al. Expression of the shortchain fatty acid receptor, GPR43, in the human colon. J Mol Histol. 2008; 39:135-42. PMID: 17899402
56. Tazoe H, Otomo Y, Karaki S, Kato I, Fukami Y, Terasaki M, et al. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res. 2009; 30:149-56. PMID: 19574715